BriaCell Therapeutics Corp. Quarterly Assets in USD from Q2 2021 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: BriaCell Therapeutics Corp. quarterly Assets history and growth rate from Q2 2021 to Q3 2024.
BriaCell Therapeutics Corp. Assets for the quarter ending October 31, 2024 was $10.4M, a 44.1% decline year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$10.4M	-$8.2M	-44.1%	Oct 31, 2024	10-Q	2024-12-16
Q2 2024	$5.87M	-$21.3M	-78.4%	Jul 31, 2024	10-Q	2024-12-16
Q1 2024	$6.2M	-$23.5M	-79.1%	Apr 30, 2024	10-Q	2024-06-14
Q4 2023	$12.2M	-$21.9M	-64.2%	Jan 31, 2024	10-Q	2024-03-18
Q3 2023	$18.6M	-$19.8M	-51.6%	Oct 31, 2023	10-Q	2023-12-14
Q2 2023	$27.2M	-$15.4M	-36.2%	Jul 31, 2023	10-K	2024-10-29
Q1 2023	$29.7M	-$16.7M	-36%	Apr 30, 2023	10-Q	2023-06-14
Q4 2022	$34.2M	-$14.4M	-29.6%	Jan 31, 2023	10-Q	2023-03-16
Q3 2022	$38.5M			Oct 31, 2022	10-Q	2022-12-14
Q2 2022	$42.6M	-$15.5M	-26.6%	Jul 31, 2022	10-K	2023-10-25
Q2 2021	$58M	+$57.5M	+11012%	Jul 31, 2021	10-K	2022-10-28

* An asterisk sign (*) next to the value indicates that the value is likely invalid.